Post
Post

IncomeSharks / ARTICLE

Healthcare a lagging sector that should see rotation Energy started the year off as the hot sector, Tech/AI had a big correction, and now it's rebounding. Still cautious on the move because they were overvalued before the dip, and now are at higher valuations. The market is really trying to stick to a narrative to push higher and I'm not trying to short the strength as it can last irrationally longer than it should. My mindset is usually to find what's next, and sometimes it works very well, other times it's annoying missing some hot trends. I chose to be conservative and play it safe instead of gambling on the AI/Tech rebound so missed out on the move. So I either can sulk for months and try FOMO chasing what's already popped or remain patient and look for the next round of winners and win back some skeptics. A good example was bidding $INTC sub $20 and catching the first massive rally off of the move. While I was waiting for that one $NVDA and other AI stocks were red hot and running. I remained patient, and ended up returning triple digits which was a larger move then the hot ones. In a perfect world should I have rode up what was hot, and rotated back? Absolutely. But would I have missed having exposure before the government announced the $INTC investment, 100%. So now to dig deep into some Healtchare plays that are leveraging AI and are showing YOY growth on healthy corrections. Earnings coming up so watching closely. $TEMP - Is an AI-driven precision medicine company focused on oncology and broader healthcare data platforms. On a 50% correction, possible support/diagonal breakout 2025 Revenue at 1.3 billion (83% YOY) Q4 2025: 367 million 2026 Estimate: 1.59 billion (25% YOY) 20227 Estimate: 1.94 billion (22% YOY) https://www.tradingview.com/x/OLTIdd5x/ $GRAL - Early cancer detection blood test. Had a great 4x run on this one last time. The results of one study caused a sell off but it seems they have more coming and overall could be another opportunity to ride this one back up. Kind of waiting more for confirmation on earnings though or price to break out. Total Revenue: $147.2M (+17% YoY from $125.6M) 2026 Revenue Estimates: $183M total revenue (+24.5% YoY consensus) 2027 Revenue Estimate: $232M (+26%+ YoY from 2026 estimates) https://www.tradingview.com/x/ktHh1yhm/ $WGS - AI powered genome sequencing for rare/pediatric diseases and cancer. 2 billion marketcap play so a little more risky but higher upside potential. 2025 Revenue - 427.5 million (41% YOY) 2026 YoY Growth: 33%, First positive adjusted net income expected 2027 YOY Growth: Around 20%, expansion into new specialties https://www.tradingview.com/x/fDG69Gz2/ Waiting for earnings on at least one of these to see if sentiment and numbers are gaining momentum.

Published Apr 26, 2026Updated Apr 26, 20267 min read
Healthcare a lagging sector that should see rotation Energy started the year off as the hot sector, Tech/AI had a big correction, and now it's rebounding. Still cautious on the move because they were overvalued before the dip, and now are at higher valuations. The market is really trying to stick to a narrative to push higher and I'm not trying to short the strength as it can last irrationally longer than it should. My mindset is usually to find what's next, and sometimes it works very well, other times it's annoying missing some hot trends. I chose to be conservative and play it safe instead of gambling on the AI/Tech rebound so missed out on the move. So I either can sulk for months and try FOMO chasing what's already popped or remain patient and look for the next round of winners and win back some skeptics. A good example was bidding $INTC sub $20 and catching the first massive rally off of the move. While I was waiting for that one $NVDA and other AI stocks were red hot and running. I remained patient, and ended up returning triple digits which was a larger move then the hot ones. In a perfect world should I have rode up what was hot, and rotated back? Absolutely. But would I have missed having exposure before the government announced the $INTC investment, 100%. So now to dig deep into some Healtchare plays that are leveraging AI and are showing YOY growth on healthy corrections. Earnings coming up so watching closely. $TEMP - Is an AI-driven precision medicine company focused on oncology and broader healthcare data platforms. On a 50% correction, possible support/diagonal breakout 2025 Revenue at 1.3 billion (83% YOY) Q4 2025: 367 million 2026 Estimate: 1.59 billion (25% YOY) 20227 Estimate: 1.94 billion (22% YOY) https://www.tradingview.com/x/OLTIdd5x/ $GRAL - Early cancer detection blood test. Had a great 4x run on this one last time. The results of one study caused a sell off but it seems they have more coming and overall could be another opportunity to ride this one back up. Kind of waiting more for confirmation on earnings though or price to break out. Total Revenue: $147.2M (+17% YoY from $125.6M) 2026 Revenue Estimates: $183M total revenue (+24.5% YoY consensus) 2027 Revenue Estimate: $232M (+26%+ YoY from 2026 estimates) https://www.tradingview.com/x/ktHh1yhm/ $WGS - AI powered genome sequencing for rare/pediatric diseases and cancer. 2 billion marketcap play so a little more risky but higher upside potential. 2025 Revenue - 427.5 million (41% YOY) 2026 YoY Growth: 33%, First positive adjusted net income expected 2027 YOY Growth: Around 20%, expansion into new specialties https://www.tradingview.com/x/fDG69Gz2/ Waiting for earnings on at least one of these to see if sentiment and numbers are gaining momentum.